_l-michael-glod-md-on-prostate-cancer-results-from-swog-s9921.jpg "L. Michael Glodé, MD, on Prostate Cancer: Results From SWOG S9921 from adt Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 2 min 74 sec
✓ Published: 21-Feb-2017
✓ Published: 21-Feb-2017
Description:
L. Michael Glodé, MD, of the University of Colorado Cancer Center, discusses study findings on adjuvant androgen deprivation vs mitoxantrone plus prednisone plus ADT in high-risk prostate cancer patients following radical prostatectomy. (Abstract 2)
L. Michael Glodé, MD, of the University of Colorado Cancer Center, discusses study findings on adjuvant androgen deprivation vs mitoxantrone plus prednisone plus ADT in high-risk prostate cancer patients following radical prostatectomy. (Abstract 2)
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
_highlights-from-asco-2019.webp "Assistant Prof Bishal Gyawali and Monique Biryiana speak at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting about the highlights from this year's conference. nnAssistant Prof Gyawali discusses several presentations that address topics ranging from racial disparities, accelerated drug approvals and the importance of assessing overall survival in clinical trials. nnThe presentations that he refer to are: nnAffordable Care Act (ACA) Medicaid expansion impact on racial dispariti")
_cbs-local-fit-newstory.webp "Fitlink Installation- Miami News Story - Intruder Caught at the Garage, OPTEX https://www.optexamerica.com/security-products/fitlink-series")
_highlights-from-asco-2019.jpg)
_cbs-local-fit-newstory.jpg)
![[+]](/images/menu.gif){kind=small}